Skip to Content

Teva wins approval for generic Tamoxifen Citrate Tablets

JERUSALEM, ISRAEL, Feb. 21, 2003 -- Teva Pharmaceutical Industries announced that the FDA  has approved the company's ANDAs for Tamoxifen Citrate Tablets USP, 10 mg and 20 mg. Shipments will begin immediately.

Tamoxifen Citrate Tablets are the AB-rated generic equivalent of AstraZeneca's Nolvadex Tablets, an anti-estrogen drug for the treatment of breast cancer.

Source: Teva Pharmaceutical Industries

Posted: February 2003